Shih-Chen Chang, PhD, 2015 CBA President Shih-Chen currently worked in Genentech as a senior Real World Data Scientist supporting infectious disease (ID) area since September 2011. Before he joined in the company, he worked at AstraZeneca for ~5 years in global epidemiology department, covering oncology and ID therapeutic areas, and spent 3.5 years for his post-doctorate training on cancer epidemiology at National Cancer Institute. He obtained his PhD in School of Public Health, Johns Hopkins, and Master of Science and Undergraduate degree from National Taiwan University.
Soon after his move to SF Bay area, Shih-Chen participated in his first 2011 CBA annual meeting and joined the CBA Committee board in 2012, supporting publication and sponsorship. He subsequently took the role as vice president in 2013 and chaired the annual conference. Shih-Chen has great passion to serve the community. Looking forward he hopes to continue building the foundation for the growing CBA, and promote this exciting organization to the greater Bay area bioscience communities.
Kai Zheng, PhD, 2015 CBA Vice President Dr. Kai Zheng received his Ph.D. from Department of Pharmaceutical Chemistry at the University of Kansas. After graduation, he joined Pharm. Technical Development department in Genentech at Oceanside, California and focused on formulation development of biotherapeutics at early stage. In 2011, Dr. Zheng joined Late Stage Pharmaceutical Development department in Genentech at South San Francisco site, where he focuses on Phase III and commercial formulation development of biotherapeutics and related regulatory filings.
He has been a board member and volunteer of Chinese Bioscience Association (CBA) in the last three years. His duty in CBA includes managing CBA membership and helping organizing numerous workshops and annual conferences.
Cheni Kwok, PhD, 2015 CBA Vice President Dr. Kwok is a Managing Partner and Founder of Linear Dreams LLC, a management consultancy and valuation software firm specialized in corporate strategy, business/corporate development, portfolio analysis, and valuation services for the life science industry.
Prior to founding Linear Dreams LLC, Dr. Kwok served as Senior Vice President, Corporate Development at Poniard Pharmaceuticals Inc., where she established corporate and business development, strategic and commercial planning, new product planning, competitive intelligence and forecasting functions. Previously, Dr. Kwok was Director of Business Development at Celera Genomics Inc., where she led the business development efforts for Celera's small molecule therapeutics. Dr. Kwok held business development positions of increasing responsibility for Exelixis Inc., where she initiated multiple partnerships and served as the alliance manager for the GlaxoSmithKline PLC (GSK) collaboration. Prior to joining Exelixis Inc., Dr. Kwok held various research management, technology assessment and alliance management roles at SmithKline Beecham PLC (now GSK).
Dr. Kwok received a bachelor's degree in biotechnology from the Imperial College of Science, Technology and Medicine, University of London, UK, and a Ph.D. in human molecular genetics from the University of Cambridge, UK. Dr. Kwok has earned the Certified Licensing Professional (CLP) credential awarded by the Licensing Executives Society. Dr Kwok is currently serving as the co-chair of Business and Career Development Committee of Chinese-American BioPharmaceutical Society (CABS), Marketing & Outreach Committee of CLP and Leadership Council Member (Chinese Unit) of the American Cancer Society. Dr. Kwok was born in Taiwan and grew up in Singapore.
Dr. Michelle Chen, Advisor Dr. Chen is a biotech entrepreneur & executive with extensive experience in biopharma, diagnostics and life sciences. She has a track record of successful leadership roles in business development, marketing and R&D. Most recently she was a business development executive at Hoffmann-La Roche responsible for global oncology licensing, collaborations and M&A. Prior to this role, she was involved in the personalized medicine effort for Roche. Dr. Chen started her biotech career in early drug discovery& development at Scios and later Abgenix as a group leader working on the assay development of antibody drugs. She then went on to gain commercial experience at Agilent Technologies and Applied Biosystems respectively. Dr. Chen received a PhD in Biochemistry from the University of Washington, followed by the post-doctoral work at UCSF and bioinformatics training at Stanford University. She has been a CBA board member, advisor and volunteer in the last five years and a FAST program advisor for BayBio dedicated to help biotech start-ups grow and succeed. She was the president of CBA 2014.
Dr. Lin Sun-Hoffman, Advisor Dr. Sun-Hoffman is a licensed patent attorney and advises on issues related to intellectual property and technology transfer matters. She also consults on biotechnology and pharmaceutical business-related matters. She helps businesses expand into China through providing strategic and practical advice on issues as diverse as government relations, research and/or business partnerships between Chinese and American companies, intellectual property protection and drug regulatory matters. She previously worked for Life Technologies/ABI, BIO, Celera Genomics, US Patent and Trademark Office and National Institutes of Health. She is the former president of Chinese Biopharmaceutical Association based in Washington DC, currently serves on board of US China Green Energy Council, a member of Bayhelix. Dr. Sun-Hoffman has a PhD in Biochemistry/Cell and Molecular Biology. She was the president of CBA 2013.
Dr. Katherine Wang, Treasurer Katherine Wang got her B.S. degree in Optics from Shandong University, and Ph.D. in Physics from Syracuse University. She worked as research scientist in Neurodegenerative Diseases Center of University of Virginia. She has years of Hands-on experiences in optical engineering, DNA sequencing, protein purification, drug-protein interactions and cell culture. Professionally trained as physicist, later she discovered that her real interest is in clinical data analysis. She is currently doing statistical programming after she led clinical programming projects at Gilead Sciences for around two years. Previously she worked as certified advanced SAS programmer and data manager as well in Clinovo. Katherine’s diligent work and enthusiasm have been well recognized. She enjoys reading, writing and Scottish Country Dancing.
Mr. Frank Lin, Taiwan Liaison Mr. Frank Lin is the Regional Sales Marketing Director at Specialdeals.com, a VC funded startup a deal-of-the-day website that features discounted gift certificates usable at local or national companies. Frank Lin is the Regional Marketing Director in US and General Manager in Asia Pacific at Matchbin, Inc, a Web 2.0 Content Management System (CMS) provider for newspaper/radio station/magazine industry. Prior to that, Mr. Lin was a Sales Operation / Marketing Specialist at VeriSilicon, a Fabless Semiconductor company. Mr. Lin now is the Marketing Manager at GBC (www.gbc.com.tw). Mr. Lin received his B.A. degree in Electrical and Computer Engineering from Purdue University and an MBA from Santa Clara University.
Mr. Andrew Teng, Taiwan Liaison Currently acting as C.S.O. at Sunwell Scientific Inc. Mr. Teng has more than 16 years of general management experience in the fields of semiconductor and Bio Science. His broad background includes P&L, operational, BD, product development, marketing, IP protection and M&A. He was a Managing Director at Ecos Lab Co. Prior to joining Ecos Lab, Mr. Teng held a senior positions with Encepho Pharmaceutical as V.P. of Business Development. Mr. Teng has extensive international experience having had direct responsibility for business development and strategic planning in Greater China. Mr. Teng has a B.S. degree from San Jose State University. Currently studying PhD in Industrial Economics at Jinan University, China.
Dr. Patrick Yang, Alliance Dr. Patrick Yang is currently Principal Scientist at Relypsa, Inc. He has been working in bay area for many years in various pharmaceutical companies in the field of CMC/analytical development. Dr. Yang obtained his Ph. D. in pharmaceutical sciences from University of the Pacific, USA. He has previously served on CBA board several terms.
Dr. Anthony Liou, Publications Dr. Anthony K. Liou obtained his Ph.D. in Molecular Cell Biology from the Institute of Cancer Research, University of London. Upon graduation, Dr. Liou had been a research fellow at UCSF and National University of Singapore. Then, he became a junior faculty at the University of Pittsburgh. His research focused on the identification and elucidation of key protein targets and their mechanism in regulating neuronal degeneration in various neurological disorders. In the summer of 2014, Dr. Liou joined Linear Dreams LLC as an Analyst.
Dr. Liou has become a board member and volunteer of Chinese Bioscience Association (CBA) in 2015 as the lead in publications. He is the Editor in Chief of the Annual Conference program.
Dr. Wenyi Chen, Membership
Mark Chen, Secretary
Hui Fang Li, Press relationship
Jing Folsom, Sponsorship
Zewen Zhu Finance Consultant
Caesar Ho, Scholarship